You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 9, September 2, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Book and Media Reviews
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Genetics
 •Genetic Disorders
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?


Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management

Edited by N. Rezaei, A. Aghamohammadi, and L. D. Notarangelo
358 pp, $149
New York, NY, Springer, 2008
ISBN-13: 978-3-5407-8537-8

JAMA. 2009;302(9):1006-1007.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Comprehensive books devoted to the primary immunodeficiency diseases are exceedingly few, but this is the second such text published in the past 3 years. The first, Primary Immunodeficiency Diseases: A Molecular and Genetic Approach (2nd ed, Oxford University Press, 2007), has been generally regarded by experts in the field as their "bible." It is an extensive and detailed reference work—a multiauthored book of 726 pages specifying all aspects of these diseases but with an emphasis on genetic defects and research.

Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management is a new 358-page book edited by 3 colleagues—2 from an active center in Tehran, the third a well-known expert from Harvard Medical School. It provides a useful and easy-to-read update, covering most of the disorders associated with defects in lymphocytes, phagocytes, and complement. This is needed because of the extraordinarily rapid advances in the understanding and treatment of primary immunodeficiency disease during . . . [Full Text of this Article]

A. D. B. Webster, MD, FRCP, FRCPath, Reviewer
Department of Immunology
University College Medical School
London, United Kingdom
adbwebster@btinternet.com



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.